The opening of the first-ever Hong Kong Pavilion at LEAP was officiated by Professor Sun Dong, Secretary for Innovation, Technology, and Industry (SITI) of the HKSAR Government, Mr Albert Wong, CEO of HKSTP and Mr Peter Yan, CEO of Cyberport. At the same occasion, HKSTP has landed a strategic MoU with Saudi Arabia’s leading technology R&D government institution, the King Abdulaziz City for Science and Technology (KACST). The MoU provides reciprocal soft-landing opportunities for companies in both regions, as well as commitment to collaborate on technology, industry best practices and support for startups across the two ecosystem networks.
Professor Sun Dong, SITI of the HKSAR Government, said, “I am deeply impressed by the energetic I&T culture and supportive programmes available at KACST. The strategic partnership between KACST and our I&T flagships will further deepen the I&T exchange between Hong Kong and Saudi Arabia, accelerate the growth and development of our start-ups and nurture more global I&T talent.”
Mr Albert Wong, CEO of HKSTP, said, “LEAP 2024 is a crossroads of culture and innovation that captures the boundless energy and ambition of the Middle East. It is also an electrifying opportunity for HKSTP and eight of our Park companies to showcase cutting-edge advancements and explore the mega potential of Saudi Arabia. We are proud to be part of the Hong Kong delegation. Hong Kong is ready to collaborate, nurture breakthroughs and partner, as we all leap into a new era of innovation.”
Leveraging the Saudi Vision 2030, HKSTP also orchestrated the “Hong Kong Healthtech Innovations Driving Global Transformation for Generations to Come” panel session at LEAP to ignite discussions on R&D, investment, and collaboration. Three Hong Kong biotech and healthtech innovation leaders: Prof Samuel Au, President of Cornerstone Robotics; Dr Zhu Tian, Co-Founder and CEO of GenEditBio and Mr Chi Man Lam, Founder and CEO of Applied Technology Group illuminated the prospects of healthtech and highlighted Hong Kong and Saudi Arabia’s shared visions and limitless opportunities in the industry. Hong Kong-based biotech startup, GenEditBio, has also made its mark in the region with the confirmed MoU with Anwa Biosciences, a leading Saudi genomic firm. Both companies are collaborating to use cutting-edge CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology to combat genetic diseases, starting with sickle cell disease.
HKSTP Park companies participating in LEAP 2024 and their innovative technologies:
https://www.hkstp.org/news-room/calling-all-global-innovators-keep-up-with-the-golden-era-of-it/
